Jun 22, 2021 / 01:00PM GMT
Sun Kim - Centogene N.V. - Chief Strategy & IR Officer
Hello, and good morning, everyone. Welcome to the Centogene Virtual Investor Event. I would like to welcome you, and you will find the webcast and presentation on Centogene's website on investors.centogene.com.
Taking a look at the agenda for today, we have again scheduled, what we're aiming at is twofold: one, introducing the team, you will hear from many of the management team members direct; and outlining how we differentiate in our offering for rare diseases today in diagnostics and offering to pharma and how we're innovating leverage in multiomics for rare disease in the future.
Management will be going through the agenda in about 90 minutes, and then we'll open the call to live Q&A with the executive team.
But before we begin, please refer to Slide 3 of the presentation, which provides information about certain statements to be made today that may be considered forward-looking statements within the meaning of the U.S. securities laws, including those regarding our strategic plans, development programs and
Centogene NV Virtual Investor Event Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot